
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇮🇹IT · Entrepreneurship#1341K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
500 to 5K🎙 ~2x weekly·110 episodes·Last published 2w ago - Monthly Reach
Unique listeners across all episodes (30 days)
1K to 10K🇮🇹100% - Active Followers
Loyal subscribers who consistently listen
400 to 4K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 14 epsHosts
Recent guests
Recent episodes
Ep. 110: Tomas Pueyo & Trey Goff On The Next Silicon Valley Might Be A New Country
Jun 4, 2026
2h 27m 21s
Ep. 109: Jonathan Anomaly on The Future of Human Enhancement, Genetic Selection & Startup Societies
May 21, 2026
1h 21m 40s
Ep. 108: The Buck Inst. President, Eric Verdin, on Pathways to Life Extension Acceleration: Alternative Pathways and Radical Hopium vs. Scientific Realism
May 8, 2026
46m 04s
Ep. 107: Sid Sijbrandij On Beating Cancer with First Principles, n = 1 Personalized Treatments and Special Access Regulatory Pathways
Apr 10, 2026
47m 22s
Ep. 106: Yaron Brook: Capitalism, Ayn Rand, and the Moral Case for Freedom
Mar 18, 2026
1h 12m 53s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/4/26 | ![]() Ep. 110: Tomas Pueyo & Trey Goff On The Next Silicon Valley Might Be A New Country✨ | new governanceurban development+4 | Trey GoffNiklas Anzinger | Infinita CityProspera+1 | — | Tomas PueyoTrey Goff+6 | — | 2h 27m 21s | |
| 5/21/26 | ![]() Ep. 109: Jonathan Anomaly on The Future of Human Enhancement, Genetic Selection & Startup Societies✨ | human enhancementgenetic selection+5 | Jonathan Anomaly | Infinita City | — | embryo selectionrational irrationality+4 | — | 1h 21m 40s | |
| 5/8/26 | ![]() Ep. 108: The Buck Inst. President, Eric Verdin, on Pathways to Life Extension Acceleration: Alternative Pathways and Radical Hopium vs. Scientific Realism✨ | life extensionlongevity research+5 | Eric Verdin | Buck InstituteInfinita City | — | aginghealthspan+5 | — | 46m 04s | |
| 4/10/26 | ![]() Ep. 107: Sid Sijbrandij On Beating Cancer with First Principles, n = 1 Personalized Treatments and Special Access Regulatory Pathways✨ | cancer treatmentpersonalized medicine+3 | Sid Sijbrandij | GitLabInfinita City | — | cancerpersonalized treatments+4 | — | 47m 22s | |
| 3/18/26 | ![]() Ep. 106: Yaron Brook: Capitalism, Ayn Rand, and the Moral Case for Freedom✨ | capitalismAyn Rand+5 | Yaron Brook | Ayn Rand InstituteYaron Brook Show | — | capitalismAyn Rand+5 | — | 1h 12m 53s | |
| 2/20/26 | ![]() Ep. 105: Andrew Hessel: Programming DNA and Engineering the Future of Life✨ | genome sequencingDNA synthesis+5 | Andrew Hessel | Infinita CityCRISPR | — | DNAgenome writing+5 | — | 1h 05m 42s | |
| 2/20/26 | ![]() Ep. 104: Ruxandra Teslo: Clinical Trials, Drug Innovation, and the Bottleneck to Biotech Abundance✨ | drug developmentclinical trials+4 | Ruxandra Teslo | FDA | AustraliaChina | drug innovationclinical trials+5 | — | 1h 02m 38s | |
| 12/17/25 | ![]() Ian Huyett on Right to Try, Christian Techno Optimism, and Biotech Federalism✨ | Right to TryChristian Techno Optimism+4 | Ian Huyett | CornerstoneThe Christian War on Death | New HampshireMontana+1 | Right to Trybiotech+6 | — | 1h 03m 20s | |
| 12/17/25 | ![]() Ep. 103: Ian Huyett on Right to Try, Christian Techno Optimism, and Biotech Federalism | Ian Huyett is an attorney at Cornerstone in New Hampshire, where he leads litigation and policy work for a network of over one hundred churches. He helped design New Hampshire’s new Right to Try framework, which provides some of the strongest protections in the U.S. for patients seeking access to experimental treatments.Read the Essay: The Christian War on DeathHow Christianity reframed mortality and unleashed biotech acceleration. In this episode, Ian and Niklas explore the alignment between serious Christian theology and biotech acceleration. Ian makes the case for combating sickness, aging, and death, challenges ideas like “death gives life meaning” or “playing God,” and explains why Christians have long driven medical innovation. The discussion then shifts to law and strategy, including the New Hampshire Right to Try bill, the role of civil liability, and how states like New Hampshire, Montana, and Florida are opening real paths for experimental treatments.More about Ian’s work:* Corner Stone Action* Ian’s XExplore Infinita City:* Explore the Archive: The Infinita City Times* Visit Infinita City* Join the Builders’ Hub on Telegram* Follow Infinita City on X This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.infinitacitytimes.com | 1h 03m 20s | ||||||
| 12/12/25 | ![]() Ep. 103: Antonio García Martínez on Crypto, Network States, and Building New Cities✨ | cryptonetwork states+4 | Antonio García Martínez | BaseCoinbase+3 | PrósperaSan Francisco+4 | cryptonetwork states+7 | — | 49m 21s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 11/28/25 | ![]() Ep. 102: Arjun Khemani: Zcash, Radical Privacy, and the New Renaissance✨ | cryptographyprivacy+5 | Arjun Khemani | ZcashBitcoin+2 | — | ZcashBitcoin+8 | — | 57m 46s | |
| 11/14/25 | ![]() Ep. 101: Bryan Caplan: Pro Market & Pro Business, the Real Ethics of Entrepreneurship✨ | free marketsentrepreneurship+4 | Bryan Caplan | George Mason UniversityMicrosoft+3 | — | entrepreneurshipfree markets+7 | — | 1h 05m 41s | |
| 10/31/25 | ![]() Ep. 100: A Conversation with Dr. Mary Ruwart: The Lost Innovation Cost of the FDA, and How Founders Can Reclaim the Right to Build✨ | FDA regulationspharmaceutical innovation+4 | Dr. Mary Ruwart | FDABig Pharma+1 | MontanaPróspera | FDAinnovation+7 | — | 1h 17m 21s | |
| 9/23/25 | ![]() Ep. 99: A Conversation with Cremieux - How to Tell Good Science from Junk, and What’s Next in US Biotech & Deregulation✨ | biotechscience+4 | Cremieux | FDAInfinita City+5 | — | p-hackingoutcome switching+6 | — | 1h 07m 52s | |
| 9/12/25 | ![]() Ep. 98: A Conversation with Adam Thierer: The War on Computation - Why AI Must Stay Permissionless✨ | AI regulationinnovation+4 | Adam Thierer | Infinita CityPermissionless Innovation+1 | — | AIregulation+5 | — | 55m 48s | |
| 8/29/25 | ![]() Ep. 97: Dr. Michael Levin on Bioelectricity, Anthrobots, and the Software of Life | In this episode, Michael Levin, Director of the Allen Discovery Center at Tufts, breaks down how his lab is rethinking regeneration, cancer, and aging, not through genetics, but through bioelectricity as the software of life.From pioneering living robots made from frog skin cells to repairing birth defects and regenerating limbs, Levin’s work shows how tissues act as intelligent agents and how future medicine will be about communicating goals to cells, not micromanaging their chemistry.We cover:* Why Levin believes the “anatomical compiler” is the endgame: designing an organ or organism on a computer and compiling it into bioelectric instructions for cells.* How cancer emerges as a breakdown of collective memory and why reconnecting cells electrically can normalize tumors without killing them.* Proof-of-concept experiments that restore normal brains in tadpoles with birth defect mutations, regenerate frog legs, and even grow functioning eyes in new locations.* The creation of Anthrobots, synthetic multicellular organisms built from adult human cells that can repair neural damage.* Why development and regeneration show that genomes don’t dictate fixed outcomes bioelectric memories do.* The philosophical implications: recognizing agency and intelligence at every level of biology.If you’re building in biotech, longevity, or frontier medicine, this is a field guide to rewriting the software of life and a preview of the systems that could make aging, cancer, and trauma solvable problems.More about Michael Levin’s work:* Dr. Michael Levin's X* Dr. Michael Levin WebsiteExplore Infinita City:* Explore the Archive: The Infinita City Times* Visit Infinita City* Join the Builders’ Hub on Telegram* Follow Infinita City on X This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.infinitacitytimes.com | 1h 01m 18s | ||||||
| 8/14/25 | ![]() Ep. 96: Digital Nomads’ Individual Sovereignty and Regulatory Hacking in International Insurance Markets - A Conversation with SafetyWing CEO Sondre Rasch | In this episode, Sondre Rasch, founder & CEO of SafetyWing, breaks down how his team is building global health insurance and infrastructure for digital nomads, and what it takes to operate in one of the most regulated industries in the world.* From policy advisor in the Norwegian government to a $50M revenue insurance company* The legal and regulatory hacks that let SafetyWing serve nomads across 180+ countries* Why differentiated products can thrive where generic ones die, even under heavy regulation* The hidden traps of “innovation labs” and how to actually partner with insurers* How SafetyWing’s Nomad Citizen program is taking first steps toward an “internet country”* How SafetyWing is the “oddly mature company” within the network state communityIf you’re building in insurance, frontier tech, or the network state space, this is a field guide to turning regulatory complexity into a moat — and building systems that outlive any single jurisdiction.More about Sondre’s work:* Sondre’s X* Safety WingExplore Infinita City:* Explore the Archive: The Infinita City Times* Visit Infinita City* Join the Builders’ Hub on Telegram* Follow Infinita City on X This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.infinitacitytimes.com | 1h 03m 39s | ||||||
| 7/17/25 | ![]() Ep. 95: The Philosophical Implications of Radical Life Extension - A Conversation with John Martin Fischer | John Martin Fischer is Distinguished Professor of Philosophy at UC Riverside and a leading thinker on death, free will, and immortality. He joins Niklas to explore:* Why most philosophers argue against immortality and why he disagrees* The logic behind boredom, meaning, and the “human shape” of life* How AI and free will intersect and what it means for future minds* Ethical blind spots in Silicon Valley’s pursuit of radical life extensionStranded Technologies Podcast is the channel for the Infinita community, dedicated to accelerating longevity biotech and building the future of innovation-friendly cities.More about GUEST'S work:* John Martin Fischer WebsiteExplore Infinita City:* Explore the Archive: The Infinita City Times* Visit Infinita City* Join the Builders’ Hub on Telegram* Follow Infinita City on X This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.infinitacitytimes.com | 1h 01m 12s | ||||||
| 7/4/25 | ![]() Ep. 94: Jose Luis “Nintil” Ricón on Metascience, Longevity Biotech Pathways and Parallel Institutions | Jose Luis Ricón Fernández de la Puente is widely known for his influential blog “Nintil” and in his current role as Head of Theory at Retro Biosciences, a leading company in the longevity biotech space funded with $180m by Sam Altman. Niklas and Jose Luis dive into:* Why the current scientific institutions often fail to deliver on its promises* The most promising pathways and bottlenecks in longevity biotech* Lessons from libertarianism and economics for building better scientific institutions* The role of network cities, special jurisdictions, and parallel systemsStranded Technologies Podcast is the channel for the Infinita community, dedicated to accelerating longevity biotech and building the future of innovation-friendly cities.More about GUEST'S work:* Retro.bio* Nintil This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.infinitacitytimes.com | 1h 12m 50s | ||||||
| 4/10/25 | ![]() Ep. 93: Cush on Latin American Dynamism, Crypto Adoption, and Building Subcultures of Relentless Ambition | Cush is the founder of Odisea Labs, an accelerator for Latin American frontier tech (crypto, AI). Cush is inspired by effective accelerationism (e/acc) and consequently coined the memes “latam/acc” and “Latin American Dynamism” in reference to their US-based counterpart.In this episode, we learn all about why Latam is awesome for tech. Financial innovation and crypto have a fertile ground here and are widely adopted due the lack of banking access for large populations, regulatory capture and government mismanagement.Odisea Labs has been a major partner to the past March Startup Residency Month, and is now announcing another partnership with Infinita City for the following:Crypto Cities Theme MonthThis is a one-month program for builders to deploy crypto-native projects, not just online, but in a functioning city with enabling legislation, crypto taxes, and a supportive community.🗓️ | June 1 - 30, 2025📍 | Próspera Zone, Roatan (Honduras)➡️ | Signup: infinita.city/crypto-cities This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.infinitacitytimes.com | 1h 00m 33s | ||||||
| 3/28/25 | ![]() Ep. 92: Jack Scannell On Eroom’s Law In Drug Development | Jack Scannell is a consultant, researcher, and entrepreneur. Jack is one of the world’s leading authorities on pharmaceutical R&D productivity. He co-authored the influential 2012 paper in Nature Reviews Drug Discovery that introduced “Eroom’s Law,” a concept highlighting how drug discovery has become slower and more expensive over time—essentially the opposite of Moore’s Law. Scannell has advised major pharmaceutical firms and is a noted commentator on strategies to improve innovation efficiency in the life sciences. He is currently building Ethereos.Explore Infinita City:* Explore the Archive: The Infinita City Times* Visit Infinita City* Join the Builders’ Hub on Telegram* Follow Infinita City on X This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.infinitacitytimes.com | 45m 55s | ||||||
| 3/19/25 | ![]() Ep. 91: JP Vergne on the Pirate Organization as the Innovators of Capitalism and Governance | Jean-Philippe (JP) Vergne is an Associate Professor of Strategy at Western University’s Ivey Business School, renowned for his research on organizations operating at the fringes of legality—particularly pirates. Along with Rodolphe Durand, he co-authored The Pirate Organization: Lessons from the Fringes of Capitalism, which explores how historical piracy and other unconventional ventures can shed light on modern forms of competition, regulation, and innovation. JP Vergne’s work extends to topics such as crypto governance, the historical development of organizations, and the evolution of capitalism.Book Reference: The Pirate Organization: Lessons from the Fringes of CapitalismExplore Infinita City:* Explore the Archive: The Infinita City Times* Visit Infinita City* Join the Builders’ Hub on Telegram* Follow Infinita City on X This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.infinitacitytimes.com | 1h 16m 50s | ||||||
| 2/19/25 | ![]() Ep. 90: Unlimited Bio’s Journey to Launch a Prospera Biotech Company - with Ivan Morgunov & Dr. Anna Vakhrusheva | Ivan Morgunov is an experienced entrepreneur driven by the goal of stopping aging. He founded Longaevus Technologies, a venture studio in the field of longevity, and Unlimited Bio—one of the two companies that administer genetic therapies in Prospera Dr. Anna Vakhrusheva has over a decade of experience in advancing vaccines and gene therapies. She led the development of Russia’s first recombinant SARS-CoV-2 vaccine (Betuvax JSC), driving it from R&D to clinical trials within two years. As a co-founder of Unlimited Bio, she spearheads genetic therapy research, translating cutting-edge science into real-world longevity solutions.In this episode, Anna & Ivan describe their journey to start a biotech company in Prospera, their novel thesis on why business model innovation matters to solve aging, the opportunity of “cocktail therapies”, regulatory fast-track options and challenges in a new jurisdiction.Explore Infinita City:* Explore the Archive: The Infinita City Times* Visit Infinita City* Join the Builders’ Hub on Telegram* Follow Infinita City on X This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.infinitacitytimes.com | 1h 04m 11s | ||||||
| 2/13/25 | ![]() Ep. 89: Nathan Cheng On His Journey To Radical Life Extension, The LBF Roadmap To Solve Aging, and The Role Of Ideology | Nathan Cheng is a community builder, educator, and investor in the longevity biotech field. He has been closely involved with key initiatives such as the Longevity Biotech Fellowship (LBF), Healthspan Capital, and Longevity List, working to solve the problem of aging and death.In this conversation, Nathan Cheng discusses his journey into the longevity biotech field, exploring the quest for an indefinite lifespan and the various strategies to combat aging. He shares insights on community building, the importance of understanding aging, and the potential of biotechnology in extending life. The conversation also delves into the technical roadmap for solving aging, replacement strategies, and the role of cryonics as a last resort. In this conversation, Nathan Chang and Niklas Anzinger discuss the importance of mission-driven research in the field of longevity, emphasizing the need for focused efforts to tackle aging and death. They explore the role of the Longevity Biotech Fellowship in mobilizing talent and fostering collaboration among diverse professionals. The discussion also touches on effective communication strategies for the longevity mission, the catalysts for progress in the field, and the opportunities for newcomers to enter the longevity space. Finally, they introduce the Vitalism Foundation, which aims to unify efforts in the longevity movement under a shared ideology.Get involved & More about Nathan's work:* Longevity Biotech Fellowship (10% off for Infinitians)* Vitalist Bay (10% off for Infinitians)* Vitalism FoundationExplore Infinita City:* Explore the Archive: The Infinita City Times* Visit Infinita City* Join the Builders’ Hub on Telegram* Follow Infinita City on X This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.infinitacitytimes.com | 1h 03m 07s | ||||||
| 1/29/25 | ![]() Ep. 88: Samo Burja on Great Founders, Institutional Change and the Fragility of Technological Progress | Samo Burja is a researcher, strategist, and founder of Bismarck Analysis and on the editorial board of Palladium Magazine. Samo is known for his work on how institutions shape civilization and his book “The Great Founder Theory.”Explore Infinita City:* Explore the Archive: The Infinita City Times* Visit Infinita City* Join the Builders’ Hub on Telegram* Follow Infinita City on X This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.infinitacitytimes.com | 1h 13m 31s | ||||||
Showing 25 of 113
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.
























